CA IX is an Independent Prognostic Marker in Premenopausal Breast Cancer Patients with One to Three Positive Lymph Nodes and a Putative Marker of Radiation Resistance
Donal J. Brennan(Mater Misericordiae University Hospital), Sallyann L. O’Brien(O'Brien Institute)
Cited by 138
Related Papers
Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
|Cancer Research|2012|941
Placenta Accreta Spectrum: A Review of Pathology, Molecular Biology, and Biomarkers
|Disease Markers|2018|244
Association of Implementing a Multidisciplinary Team Approach in the Management of Morbidly Adherent Placenta With Maternal Morbidity and Mortality
|Obstetrics and Gynecology|2018|65
Cesarean scar niche: An evolving concern in clinical practice
|International Journal of Gynecology & Obstetrics|2022|62